Stocks and Investing Stocks and Investing
Fri, February 28, 2020
Thu, February 27, 2020

Carter Gould Initiated (BIIB) at Buy and Held Target at $389 on, Feb 27th, 2020


Published on 2024-10-26 22:45:53 - WOPRAI, Carter Gould
  Print publication without navigation


Carter Gould of Barclays, Initiated "Biogen Inc." (BIIB) at Buy and Held Target at $389 on, Feb 27th, 2020.

Carter has made no other calls on BIIB in the last 4 months.



There are 11 other peers that have a rating on BIIB. Out of the 11 peers that are also analyzing BIIB, 4 agree with Carter's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Salim Syed of "Mizuho" Maintained at Hold with Increased Target to $316 on, Tuesday, February 25th, 2020
  • Evan Seigerman of "Credit Suisse" Maintained at Hold with Increased Target to $330 on, Thursday, February 6th, 2020
  • Mohit Bansal of "Wells Fargo" Maintained at Hold with Increased Target to $311 on, Thursday, February 6th, 2020
  • Alethia Young of "Cantor Fitzgerald" Reiterated at Hold with Increased Target to $361 on, Thursday, February 6th, 2020


These are the ratings of the 7 analyists that currently disagree with Carter


  • Christopher Marai of "Nomura" Maintained at Strong Buy with Increased Target to $392 on, Friday, February 7th, 2020
  • Marc Goodman of "SVB Leerink" Maintained at Buy with Increased Target to $410 on, Thursday, February 6th, 2020
  • Matthew Harrison of "Morgan Stanley" Maintained at Sell with Increased Target to $302 on, Thursday, February 6th, 2020
  • Brian Skorney of "Baird" Maintained at Sell with Increased Target to $290 on, Thursday, February 6th, 2020
  • Robyn Karnauskas of "SunTrust Robinson Humphrey" Maintained at Strong Buy with Increased Target to $360 on, Monday, February 3rd, 2020
  • Sumant Kulkarni of "Canaccord Genuity" Upgraded from Hold to Strong Buy and Held Target at $360 on, Monday, January 27th, 2020
  • Aaron Gal of "Bernstein" Upgraded from Hold to Buy on, Wednesday, October 30th, 2019
Contributing Sources